Jacobson Pharma Corporation Limited (HKG:2633)
Hong Kong · Delayed Price · Currency is HKD 1.270
0.00 (0.00%)
At close: Feb 13, 2026
HKG:2633 Cash Flow Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 302.58 | 300.83 | 266.97 | 251.04 | 177.67 | 173.71 |
Depreciation & Amortization | 148.94 | 143.87 | 141.82 | 148.65 | 187.91 | 186.76 |
Other Amortization | - | - | - | - | 4.69 | 4.94 |
Loss (Gain) From Sale of Assets | 4.1 | 4.1 | 0.06 | 3.55 | -0.25 | -1.07 |
Asset Writedown & Restructuring Costs | 30.32 | 30.32 | 7.43 | - | -5.55 | -0.49 |
Loss (Gain) From Sale of Investments | 0.84 | 0.84 | -1.62 | -8.9 | -3.3 | -7.46 |
Loss (Gain) on Equity Investments | -0.4 | -0.4 | 0.44 | 3.56 | 3.77 | 5.53 |
Stock-Based Compensation | 15.35 | 15.35 | 19.37 | 19.14 | - | - |
Other Operating Activities | -14.08 | 35.93 | -15.52 | 1 | 42.46 | 47.56 |
Change in Accounts Receivable | 38.92 | 38.92 | -68.27 | 23.78 | -62.79 | -38.82 |
Change in Inventory | -15.02 | -15.02 | -9.3 | -53.45 | 41.63 | 20.93 |
Change in Accounts Payable | -27.98 | -27.98 | 63.85 | 116.5 | 20.72 | 17.68 |
Operating Cash Flow | 483.58 | 526.78 | 484.36 | 630.09 | 406.94 | 409.26 |
Operating Cash Flow Growth | -0.37% | 8.76% | -23.13% | 54.84% | -0.57% | 13.25% |
Capital Expenditures | -248.38 | -248.38 | -129.51 | -63 | -63.86 | -63.35 |
Sale of Property, Plant & Equipment | 0.58 | 1.12 | 0.24 | 0.52 | 0.08 | 0.32 |
Cash Acquisitions | 3.88 | - | - | 0.91 | -11.43 | -240.73 |
Divestitures | - | - | - | - | - | 40.6 |
Sale (Purchase) of Intangibles | 21.53 | - | - | - | - | - |
Investment in Securities | -145.35 | -63.31 | 144.45 | -91.56 | 22.46 | -112.25 |
Other Investing Activities | 8.44 | 12.82 | 28.17 | 18.15 | 2.82 | 2.09 |
Investing Cash Flow | -359.31 | -297.76 | 43.34 | -134.98 | -49.94 | -373.31 |
Long-Term Debt Issued | - | 530 | 852 | 1,560 | 967 | 1,211 |
Total Debt Issued | 1,050 | 530 | 852 | 1,560 | 967 | 1,211 |
Long-Term Debt Repaid | - | -554.28 | -1,610 | -1,388 | -1,247 | -1,236 |
Total Debt Repaid | -895.71 | -554.28 | -1,610 | -1,388 | -1,247 | -1,236 |
Net Debt Issued (Repaid) | 154.29 | -24.28 | -757.52 | 172.3 | -279.52 | -25.2 |
Issuance of Common Stock | - | - | 38.9 | - | - | - |
Repurchase of Common Stock | -6.63 | -6.08 | -7.69 | -32.42 | - | -1.5 |
Common Dividends Paid | -359.4 | -59.57 | -93.6 | -104.03 | -51.72 | -63.22 |
Other Financing Activities | -33.76 | -41.37 | -233.34 | -72.45 | -26.65 | 111.27 |
Financing Cash Flow | -245.49 | -131.3 | -1,053 | -36.6 | -357.89 | 21.36 |
Foreign Exchange Rate Adjustments | 0.39 | -0.62 | 1.07 | -0.74 | -0.81 | 1.61 |
Net Cash Flow | -120.84 | 97.11 | -524.48 | 457.77 | -1.7 | 58.91 |
Free Cash Flow | 235.19 | 278.39 | 354.85 | 567.09 | 343.08 | 345.9 |
Free Cash Flow Growth | -33.91% | -21.55% | -37.43% | 65.29% | -0.82% | 24.89% |
Free Cash Flow Margin | 15.34% | 17.66% | 24.18% | 44.74% | 21.50% | 23.92% |
Free Cash Flow Per Share | 0.12 | 0.14 | 0.18 | 0.30 | 0.18 | 0.18 |
Cash Interest Paid | 3.26 | 2.47 | 1.68 | 1.59 | 1.48 | 2.03 |
Cash Income Tax Paid | 63.89 | 61.37 | 56.93 | 47.6 | 33.98 | 27.35 |
Levered Free Cash Flow | 83.78 | 231.07 | 260.88 | 345.79 | 285.35 | 259.98 |
Unlevered Free Cash Flow | 104.88 | 256.93 | 310.07 | 384.17 | 301.41 | 278.82 |
Change in Working Capital | -4.08 | -4.08 | -13.73 | 86.83 | -0.44 | -0.21 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.